The biologic basis for the treatment of acute stroke

Neurology

Volumn 41, Issue 12, 1991, Pages 1867-1873

  Scheinberg, Peritz ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CITICOLINE; DEXTROMETHORPHAN; DIZOCILPINE; GANGLIOSIDE GM1; N METHYL DEXTRO ASPARTIC ACID; NALOXONE; NIMODIPINE; PENTOXIFYLLINE; PLASMINOGEN ACTIVATOR; PROSTACYCLIN; STREPTOKINASE; UROKINASE;

AUTOREGULATION; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN TEMPERATURE; HUMAN; LACTIC ACIDOSIS; NERVE CELL NECROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STROKE;

ACIDOSIS, LACTIC; ACUTE DISEASE; ANIMAL; BRAIN; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; ENERGY METABOLISM; HUMAN;

EID: 0026346853     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.41.12.1867     Document Type: Article

References (86)

1. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 1981;12:723-725.
2. Hossmann K-A. Treatment of experimental cerebral ischemia. J Cereb Blood Flow Metab 1981;2:275-297.
3. Selman WR, Spetzler RF. Therapeutics for focal cerebral ischemia. Neurosurgery 1980;6:446-452.
4. Siesjo BK. Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab 1981;1:155-185.
5. Wiebers DO, Adams HP Jr, Whisnant JP. Animal models of stroke: are they relevant to human disease? Stroke 1990;21:1-3.
6. Ginsberg MD, Busto R. Rodent models of cerebral ischemia. Stroke 1989;20:1627-1642.
7. Molinari GF. Why model strokes? Stroke 1988;19:1195-1197.
8. Scheinberg P. Cerebral blood flow in vascular disease of the brain. With observations on the effects of stellate ganglion block. Amer J Med 1950;8:139-152.
9. Scheinberg P, Meyer JS, Reivich M, Sundt TM Jr, Waltz AG. Report of the Joint Committee for Stroke Facilities. XIII. Cerebral circulation and metabolism in stroke. Stroke 1976;7:211-234.
10. Fieschi C, Agnoli A, Battistini N, et al. Derangement of regional cerebral blood flow and of its regulatory mechanisms in acute cerebrovascular lesions. Neurology 1968;18:1166-1179.
11. Lassen NA. The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localized within the brain. Lancet 1966;2:1113-1115.
12. Cronqvist S, Laroche F. Transitory “hyperemia” in focal cerebral vascular lesions studied by angiography and regional CBF measurements. Br J Radiol 1967;40:270-274.
13. Harper AM. Autoregulation of cerebral blood flow: influence of the arterial blood pressure on the blood flow through the cerebral cortex. J Neurol Neurosurg Psychiatry 1966;29:398-403.
14. Waltz AG. The effect of blood pressure on blood flow in ischemic and in non-ischemic cerebral cortex: the phenomenon of autoregulation and luxury perfusion. Neurology 1968;18:613-621.
15. Paulson OB. Regional cerebral blood flow in apoplexy due to occlusion of the middle cerebral artery. Neurology 1970;20:63-77.
16. Kogure K, Busto R, Scheinberg P, et al. Energy metabolites and water content in rat brain during early stages of development of cerebral infarction. Brain 1974;97:103-114.
17. Kuhl DE, Phelps ME, Kowell AP, et al. Effects of stroke on local cerebral metabolism and perfusion: mapping by emission computed tomography of 18-FDG and 13-NH3. Ann Neurol 1980;8:47-60.
18. Pappata S, Tran Dinh S, Baron JC, et al. Remote metabolic effects of cerebrovascular lesions: magnetic resonance and positron tomography imaging. Neuroradiology 1987;29:1-6.
19. Rango M, Candelise L, Perani D, et al. Cortical pathophysiology and clinical neurologic abnormalities in acute cerebral ischemia. A serial study with single photon emission computed tomography. Arch Neurol 1989;46:1318-1322.
20. Baron JC. Positron emission tomography in cerebral ischemia: a review. Neuroradiology 1985;27:509-516.
21. Sette G, Baron JC, Mazoyer B, et al. Local brain hemodynamics and oxygen metabolism in cerebrovascular disease: positron emission tomography. Brain 1989;112:931-951.
22. Fieschi C, Agnoli A, Prencide M, et al. Impairment of the regional response of cerebral vessels to hypercarbia in vascular diseases. Eur Neurol 1969;2:13-30.
23. Jayne HW, Scheinberg P, Rich M, Belle MS. The effect of intravenous papaverine HC1 on the cerebral circulation. J Clin Invest 1952;31:111-114.
24. Yamaguchi T, Regli F, Waltz AG. Effect of Paco2 on hyperemia and ischemia in experimental cerebral infarction. Stroke 1971;2:139-147.
25. Christensen MS. Stroke treated with prolonged hyperventilation. In: Russell IN, Ross RW, eds. Brain and blood flow. London: Pitmans, 1971.
26. Zivin JA, Grotta JC. Animal stroke models: they are relevant to human disease. Stroke 1990;21:981-983.
27. Waltz AG, Sundt TM Jr, Owen CA. Effect of middle cerebral artery occlusion on cortical blood flow in animals. Neurology 1966;16:1185-1190.
28. Blair G, Waltz AG. Regional cerebral blood flow during acute ischemia. Correlation of autoradiographic measurements with observations of cortical microcirculation. Neurology 1970;20:802-808.
29. Halsey JH Jr, Clark LC Jr. Some regional circulatory abnormalities following experimental cerebral infarction. Neurology 1970;20:238-246.
30. Sundt TM, Waltz AG. Cerebral ischemia and reactive hyperemia: studies of cortical blood flow and microcirculation before, during, and after temporary occlusion of middle cerebral artery of squirrel monkey. Circ Res 1971;28:426-433.
31. Symon L, Ganz GC, Dorsch NWC. Experimental studies of hyper- aemic phenomena in the cerebral circulation of primates. Brain 1972;95:265-278.
32. Astrup J, Symon L, Branston NM, Lassen NA. Cortical evoked potential and extracellular K + and H + at critical levels of brain ischemia. Stroke 1977;8:51-57.
33. Scarbrough FW, Messick JM Jr, Sundt TM Jr. Correlation of continuous electroencephalograms with cerebral blood flow measurements during carotid endarterectomy [abstract]. Stroke 1973;4:352.
34. Kogure K, Kishikawa H, Busto R, et al. Cerebral blood flow in acute experimental stroke in rats. Acta Neurol Scand 1977;56:224-225.
35. Branston NM, Strong AJ, Symon L. Extracellular potassium activity, evoked potential and tissue blood flow. J Neurol Sci 1977;32:305-321.
36. Morawetz RB, Crowell RH, DeGirolami U, Marcoux FW, Jones TH, Halsey JH. Regional cerebral blood flow thresholds during cerebral ischemia. Fed Proc 1979;38:2493-2494.
37. Heiss WD, Hayakawa T, Waltz AG. Cortical neuronal function during ischemia: effects of occlusion of one middle cerebral artery on single unit activity in cats. Arch Neurol 1976;33:813-820.
38. Siesjo BK, Wieloch T. Cerebral metabolism in ischemia: neurochemical basis for therapy. Br J Anaesth 1985;57:47-62.
39. Siesjo BK. Cerebral circulation and metabolism. J Neurosurg 1984;60:883-908.
40. Kogure K, Scheinberg P, Matsumoto A, Busto R, Reinmuth OM. Catecholamines in experimental brain ischemia. Arch Neurol 1975;32:21-24.
41. Burkard WP. Catecholamine induced increase of cyclic adenosine 3', 5' monophosphate in rat brain in vivo. J Neurochem 1972;19:2615-2619.
42. Bartko D, Revlen HJ, Koch H, Schurmann K. Effect of dex- amethosone on the early edema following occlusion of the middle cerebral artery in cats. In: Reulen HJ, Schurmann K, eds. Steroids and brain edema. New York: Springer-Verlag, 1972:127-137.
43. Klatzo I. Brain oedema following brain ischemia and the influence of therapy. Br J Anaesth 1985;57:18-22.
44. Chan PH, Fishman RA. Brain edema. In: Lajtha A, ed. Handbook of neurochemistry, vol 10. New York: Plenum, 1985:153-174.
45. Anderson DC, Cranford RE. Corticosteroids in ischemic stroke. Stroke 1979;10:68-71.
46. Siesjo BK. Acid-base homeostasis in the brain: physiology, chemistry, and neurochemical pathology. Prog Brain Res 1985;63:121-154.
47. Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J. Free radicals in cerebral ischemia. Stroke 1978;9:445-447.
48. Ginsberg MD, Busto R, Yoshida S, et al. Mechanisms of irreversible injury in cerebral ischemia. J Cereb Blood Flow Metab 1982;2:263-264.
49. Siesjo BK, Wieloch T. Molecular mechanisms of ischemic brain damage: Ca2+ related events. In: Plum F, Pulsinelli W, eds. Cerebrovascular disease. New York: Raven Press, 1985:187-197.
50. Wieloch T. Neurochemical correlates to selective neuronal vulnerability. Prog Brain Res 1985;63:69-85.
51. Rothman SM, Olney JW. Excitotoxicity and the NMD A receptor. Trends Neurosc 1987;10:299-302.
52. Albers GW, Goldberg MP, Choi DW. IV-methyl-D-asparate antagonists: ready for clinical trial in brain ischemia? Ann Neurol 1989;25:398-403.
53. Globus MY-T, Busto R, Dietrich WD, et al. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma- aminobutyric acid studied by intracerebral microdialysis. J Neu- rochem 1988;51:1455-1464.
54. Barsan WG, Brott TG, Olinger CP, et al. Identification and entry of the patient with acute cerebral infarction. Ann Emerg Med 1988;17:1192-1195.
55. Hsu CY, Norris JW, Hogan EL, and the pentoxifylline study group. Pentoxifylline in acute non-hemorrhagic stroke: a randomized, placebo-controlled double blind trial. Stroke 1988;19:716-722.
56. Scandinavian Stroke Study Group. Multicenter trial of hemodilu- tion in acute ischemic stroke. Results of sub-group analyses. Stroke 1988;19:468-471.
57. Wood JH, Kee DB Jr. Hemorheology of the cerebral circulation in stroke. Stroke 1985;16:765-772.
58. Italian Acute Stroke Study Group. The Italian hemodilution trial in acute stroke. Stroke 1987;18:670-676.
59. Hsu CY, Faught RE Jr, Furlan AJ, et al. Intravenous prostacyclin in acute non-hemorrhagic stroke: a placebo controlled double blind trial. Stroke 1987;18:352-358.
60. Martin JF, Hamdy N, Nicholl J, et al. Double blind control of prostacyclin in cerebral infarction. Stroke 1985;16:386-390.
61. DelZoppo GJ, Zeumer H, Harker LA. Thrombolytic therapy in stroke: possibilities and hazards. Stroke 1986;17:595-607.
62. Zivin JA, Fisher M, DeGirolami J, et al. Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 1985;230:1289-1292.
63. Lyden PD, Zivin JA, Clark WA, et al. Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits. Neurology 1989;39:703-708.
64. Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Therapeutic thrombolysis in cerebral thromboembolism: double blind evaluation of intravenous plasmin therapy in carotid and middle cerebral artery occlusion. Neurology 1963;13:927-937.
65. Bleyaert AL, Nemoto EM, Safar P, et al. Thiopental amelioration of brain damage after global ischemia in monkeys. Anaesthesia 1978;49:390-398.
66. Smith AL, Hoff JT, Nielsen SL, Larson CP. Barbiturate protection in acute focal cerebral ischemia. Stroke 1974;5:1-7.
67. Flamm ES, Demopoulos HB, Seligman ML, Ransohoff J. Possible molecular mechanisms of barbiturate-mediated protection in regional cerebral ischemia [abstract]. Acta Neurol Scand 1977;56(suppl 64):150-151.
68. Yatsu FM, Pettigrew LC Jr, Grotta JC. Medical therapy of ischemic strokes. In: Barnett HJM, Stein BM, Mohr JP, Yatsu FM, eds. Stroke: pathophysiology, diagnosis and management, vol 2. New York: Churchill Livingstone, 1986:1069-1083.
69. Rosomoff HL., Hypothermia and cerebral vascular lesions. I. Experimental interruption of the middle cerebral artery during hypothermia. J Neurosurg 1956;13:332-343.
70. Steen PA, Soule EH, Michenfelder JP. Detrimental effect of prolonged hypothermia in cats and monkeys with and without regional cerebral ischemia. Stroke 1979;10:522-529.
71. Busto R, Dietrich WD, Globus MY-T, et al. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 1987;7:729-738.
72. Minamisawa H, Smith ML, Siesjo BK. The effect of mild hyperthermia and hypothermia on brain damage following 5,10, and 15 minutes of forebrain ischemia. Ann Neurol 1990;28:26-35.
73. Steen PA, Gisvold SE, Milde JM, et al. Nimodopine improves outcome when given after complete cerebral ischemia in primates. Anaesthesia 1985;62:406-414.
74. Gelmers HJ, Gorter K, DeWeerdt CJ, Wiezer HJA. A controlled trial of nimodopine in acute ischemic stroke. N Engl J Med 1988;318:203-207.
75. Martinez-Vila E, Guillen F, Villaneuva JA, et al. Placebo-controlled trial of nimodopine in the treatment of acute ischemic cerebral infarction. Stroke 1990;21:1023-1028.
76. Germano IM, Pitts LH, Meldrum BS, et al. Kynurenate inhibition of cell excitation decreases stroke size and defects. Ann Neurol 1987;22:730-734.
77. Hattori H, Morin AM, Schwartz PH, Fujikawa DG, Wasterlain CG. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology 1989;39:713-718.
78. Stevens MK, Yaksh TL., Systemic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEG, and blood-brain barrier following complete reversible cerebral ischemia. J Cereb Blood Flow Metab 1990;10:77-88.
79. Ginsberg MD, Welsh FA, Budd WW. Deleterious effect of glucose pretreatment on recovery from diffuse cerebral ischemia in the cat. I. Local cerebral blood flow and glucose utilization. Stroke 1980;11:347-354.
80. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate hyperglycemia augments ischemic brain damage: a neu- ropathologic study in the rat. Neurology 1982;32:1239-1246.
81. Woo E, Chan YW, Yu YL, Huang CY. Admission glucose level in relation to mortality and morbidity outcome in 252 stroke patients. Stroke 1988;19:185-191.
82. Berger L, Hakim AM. The association of hyperglycemia with cerebral edema in stroke. Stroke 1986;17:865-871.
83. Fallis RJ, Fisher M, Lobo RA. A double-blind trial of naloxone in the treatment of acute stroke. Stroke 1984;15:627-629.
84. Fadem AL Opiate antagonists in the treatment of stroke. Stroke 1984;15:575-577.
85. Argentino C, Sacchetti ML, Toni D, et al. GM, ganglioside therapy in acute ischemic stroke. Stroke 1989;20:1143-1149.
86. Tazaki Y, Sakai F, Otomo E, et al. Treatment of cerebral infarction with a choline precursor in a multi-center double blind placebo-controlled study. Stroke 1988;19:211-216.